Nanotechnology Reviews, published by DE GRUYTER POLAND SP Z O O, stands at the forefront of the multidisciplinary field of nanoscience and nanotechnology. With an Open Access model adopted since 2019, this journal, identifiable by its ISSN 2191-9089 and E-ISSN 2191-9097, disseminates vital research that is accessible to a global audience. The journal is located in Germany and has established itself as a premier platform for innovative research, boasting impressive quartile rankings: Q1 across several categories including Biotechnology, Energy Engineering, and Materials Science, as well as a Q2 classification in Biomaterials as of 2023. The diverse scope enables authors to contribute to a range of topics, from biomedical applications to energy solutions and advanced materials, making it essential reading for researchers, professionals, and students passionate about cutting-edge developments. Additionally, with Scopus rankings highlighting its value across various domains and robust percentiles, including 94 in Engineering (miscellaneous), 93 in Medicine (miscellaneous), and 88 in Biotechnology, Nanotechnology Reviews is an influential and respected journal that fosters scientific dialogue and innovation.

ChemNanoMat is a prestigious academic journal published by WILEY-V C H VERLAG GMBH, dedicated to the rapidly evolving fields of nanoscale materials and their applications in diverse areas such as biomaterials, energy engineering, and environmental sustainability. With the journal's ISSN 2199-692X and recognized quality, as evidenced by its Q2 rankings across multiple categories—including Biomaterials and Renewable Energy—ChemNanoMat serves as a crucial platform for researchers, professionals, and students to disseminate their findings and foster collaborations. Operating from Germany, the journal encourages the exploration of innovative materials solutions to meet tomorrow's challenges. While it does not currently offer open access options, it remains highly regarded in the academic community with a competitive impact factor that emphasizes its relevance and influence in guiding future research directions. Covering a broad scope from 2015 through 2024, ChemNanoMat is key for anyone invested in the advancement of materials chemistry and related scientific fields.

Nano LIFE, published by World Scientific Publishing Company, is a multidisciplinary journal that delves into the dynamic fields of bioengineering, biomedical engineering, and pharmaceutical science, providing a platform for researchers to disseminate their cutting-edge findings. With an ISSN of 1793-9844 and e-ISSN 1793-9852, this journal emphasizes the significance of nanoscale research in healthcare and technology, positioning itself as a vital resource for professionals and academics alike. Although currently categorized in the Q4 quartile for multiple scientific disciplines in 2023, its unique focus on the intersection of nanotechnology and life sciences aims to elevate the discourse in these rapidly evolving sectors. Researchers can anticipate publishing innovative methodologies and results, contributing to the overall understanding and application of nanotechnology in medicine. Located in Singapore, Nano LIFE not only serves the global research community but also reflects the growing interest in nanotechnology across diverse fields.

Nanotoxicology is a pioneering journal published by Taylor & Francis Ltd, dedicated to the critical examination of the toxicity of nanomaterials and their implications in biomedical engineering, nanoscience, and toxicology. With an ISSN of 1743-5390 and E-ISSN of 1743-5404, this journal has established itself as a significant player in its field since its inception in 2007. Classified within the Q2 category for 2023 in major categories such as Biomedical Engineering, Nanoscience and Nanotechnology, and Toxicology, it reflects its robust impact across interdisciplinary research. Notably, its Scopus rankings position it in the top percentile, underscoring its influence in pharmacology and toxicology. The journal offers scholars, researchers, and professionals a platform for sharing pioneering studies and reviews, thereby advancing the understanding of nanomaterial interactions with biological systems. Published from the United Kingdom, Nanotoxicology recognizes the growing importance of nanotechnology in health and environmental contexts, making it an essential resource for anyone engaged in this rapidly evolving field.

The Journal of Experimental Nanoscience, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing the field of nanoscience and its applications across various disciplines. Since its establishment, the journal has aimed to provide a comprehensive platform for researchers and professionals to disseminate innovative findings in nanotechnology, bioengineering, and materials science. With an ISSN of 1745-8080 and E-ISSN of 1745-8099, this journal has been pivotal in promoting high-quality research in its converged years from 2006 to 2024. Recognized for its contributions, it currently holds a Q3 ranking in core categories such as Bioengineering, Biomedical Engineering, Materials Science, and Nanoscience and Nanotechnology. Although its H-index is not specified, its Scopus ranks reflect its growing influence, with notable percentiles in various engineering fields. By offering open access since 2016, the Journal of Experimental Nanoscience enhances the accessibility of vital research to a global audience. Researchers, professionals, and students will find this journal an invaluable resource for staying abreast of the latest advancements and breakthroughs in nanoscience.

Nanoscale Advances, published by the Royal Society of Chemistry, stands out as a leading open-access journal dedicated to advancing the field of nanoscience and nanotechnology since its inception in 2018. With a specialized focus on areas such as atomic and molecular physics, bioengineering, chemistry, and materials science, this journal has consistently achieved top-tier rankings across several categories, reflecting its high-impact contribution to research and innovation. Currently classified in the Q1 quartile for both Atomic and Molecular Physics and Chemistry (Miscellaneous), and Q2 for Bioengineering, its prestige is underscored by impressive Scopus rankings, including a notable 34th position in General Engineering. With its commitment to disseminating high-quality research, Nanoscale Advances serves as an invaluable resource for researchers, professionals, and students alike, fostering collaboration and scholarly exchange in the rapidly evolving landscape of nanotechnology.

Materials Today is a premier academic journal published by Elsevier Science Ltd, specializing in the dynamic fields of materials science, mechanical engineering, and condensed matter physics. Established in 1999, the journal has garnered an enviable reputation, consistently ranking in the Q1 category across multiple disciplines including mechanics of materials and general materials science, reflecting its influence and high-quality research output. With an impressive Scopus ranking—4th in both mechanical engineering and mechanics of materials, and 6th in condensed matter physics—Materials Today serves as an essential resource for researchers, professionals, and students seeking to stay at the forefront of developments in material innovations and applications. The journal is known for its commitment to publishing significant research findings and reviews, making it a vital platform for disseminating knowledge and fostering collaboration in the rapidly evolving materials field. Although it does not offer open access, its robust impact factor underscores the importance of the content published, ensuring wide visibility and citation among the academic community. Explore the rich tapestry of materials research with Materials Today, where groundbreaking insights pave the way for future technological advancements.

Cancer Nanotechnology is a cutting-edge peer-reviewed journal dedicated to advancing the field of cancer research through innovative nanotechnology applications. Published by SPRINGER WIEN, this open-access journal, established in 2010, provides a vital platform for the dissemination of high-quality research with a focus on the intersection of nanotechnology, oncology, and biomedical engineering. With a commitment to promoting accessibility and fostering collaboration, Cancer Nanotechnology has gained impressive rankings within specialized categories, including Q2 in Biomedical Engineering and Pharmaceutical Science. The journal's rigorous selection process ensures that only the most impactful studies reach its audience, making it a must-read for researchers, professionals, and students eager to explore the latest advancements and methodologies in cancer treatment. With its scope encompassing critical topics that bridge multiple disciplines—including physical chemistry and toxicology—Cancer Nanotechnology positions itself as an influential resource for shaping the future of cancer therapies.

Current Nanoscience is a prominent journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of nanoscience through the dissemination of high-quality research and review articles. Since its inception in 2006, the journal has provided a platform for innovative studies across a variety of related disciplines, including bioengineering, biomedical engineering, biotechnology, and nanotechnology, reflecting its diverse scope and interdisciplinary nature. With a Q3 ranking in several categories such as Biomedical Engineering and Pharmaceutical Science and a Scopus percentile ranking around the 60th in its field, Current Nanoscience serves as a vital resource for researchers and professionals seeking to stay abreast of the latest developments and breakthroughs. Although it operates without an open access model, the journal maintains a commitment to enhancing accessibility and relevance in the scientific community. The editorial team is focused on publishing articles that address both theoretical and practical aspects of nanoscience, ensuring that the findings contribute to knowledge and innovation in areas critical to technology and healthcare.

Nanomedicine, published by Future Medicine Ltd, is a premier academic journal dedicated to the rapidly evolving field of nanotechnology in medicine. With an emphasis on innovative research and applications, this journal encompasses a broad spectrum of topics including bioengineering, biomedical engineering, and nanoscience, among others. Featuring an impressive Q1 ranking in Development and multiple Q2 rankings across significant categories, it serves as a pivotal resource for researchers and professionals aiming to stay at the forefront of advancements in these disciplines. While the journal is not open access, it is accessible through various institutional subscriptions, ensuring wide dissemination of cutting-edge findings. Notably, it has achieved substantial impact within the scientific community, indicated by its high rankings in Scopus and overall commitment to enhancing the understanding and application of nanomedicine. This journal is a vital conduit for fostering collaborations and innovations that transcend traditional medical paradigms.